Typically, tumor cells express Toll-like receptor 4 (TLR4), and the activation of TLR4 signaling pathways results in cytoskeleton modifications, causing T-MPs to shed from cell membrane surfaces [21,22]. This evidence concerns the gene TLR4 and neoplasm.